Repositioning Candidate Details
Candidate ID: | R0687 |
Source ID: | DB05053 |
Source Type: | investigational |
Compound Type: | small molecule |
Compound Name: | MB-07803 |
Synonyms: | -- |
Molecular Formula: | C24H37N4O7PS |
SMILES: | CCOC(=O)C(C)(C)NP(=O)(NC(C)(C)C(=O)OCC)C1=CC=C(O1)C1=C(SC(N)=N1)C(=O)C(C)(C)C |
Structure: |
|
DrugBank Description: | MB07803 is a second generation gluconeogenesis inhibitor for the treatment of type 2 diabetes. It is designed to block the metabolic pathway in the liver that is responsible for producing glucose. |
CAS Number: | 882757-24-6 |
Molecular Weight: | 556.61 |
DrugBank Indication: | Investigated for use/treatment in diabetes mellitus type 2. |
DrugBank Pharmacology: | -- |
DrugBank MoA: | MB07803 is a selective inhibitor of fructose-1, 6-bisphosphatase (FBPase), a regulatory enzyme in the pathway responsible for the production of glucose in the liver, known as the gluconeogenesis pathway. By specifically inhibiting this pathway, liver glucose production should be reduced and blood sugar levels decreased in patients with diabetes, independent of insulin levels and body weight. |
Targets: | Fructose-1,6-bisphosphatase 1 |
Inclusion Criteria: | Indication associated |

Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
---|
Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
---|
Diseases ID | DO ID | Disease Name | Definition | Class | |
---|---|---|---|---|---|
I05 | 9352 | Type 2 diabetes mellitus | A diabetes that is characterized by chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action, or both. A diabetes mellitus that is characterized by high blood sugar, insulin resistance, and relative lack of insulin. http://en.wikipedia.org/wiki/Diabetes, http://en.wikipedia.org/wiki/Diabetes_mellitus_type_2 | disease of metabolism/inherited metabolic disorder/ carbohydrate metabolic disorder/glucose metabolism disease/diabetes/ diabetes mellitus | Details |